Kraig Biocraft Laboratories Announces Investor Web Conference Highlighting Commercialization Progress of Spider Silk Technologies

ANN ARBOR, Mich., – December 3, 2024 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the leading developer of spider silk-based fibers, today announced it will be publishing its investor web conference on December 4, at 4:30 pm ET. This conference provides an in-depth review of the Company’s amazing progress over the past twelve months in commercializing its revolutionary spider silk fibers.

“This has been an amazing year for Kraig Labs and for commercial scale production of recombinant spider silk for the textile markets. I am excited to share the record-setting progress Kraig Labs made this year in scaling up our spider silk production and in the development of the next generation of super fibers,” said Company Founder and CEO, Kim Thompson. “This shareholder conference will highlight the substantial business model progress we have made this year, as well as some of our upcoming targets and goals.”

Interested viewers will be able to find the video at www.kraiglabs.com/videos or through the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270 starting on December 4, at 4:30 pm ET. 

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Kraig Biocraft Laboratories, Inc.

2723 South State Street Suite 150
Ann Arbor, Michigan 48104

Phone: (734) 619-8066

Corporate Website: www.KraigLabs.com

Email: corporate@KraigLabs.com